XML 62 R52.htm IDEA: XBRL DOCUMENT v3.23.2
Stock Based Compensation - Additional Information (Detail) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 6 Months Ended
Sep. 30, 2018
Jun. 30, 2023
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]          
Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount   $ 30.2 $ 30.2    
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition     2 years 11 months 4 days    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number   15,383,418 15,383,418   12,063,560
Restricted common stock, vesting in equal monthly installments     10 years    
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage     25.00%    
Aggregate Intrinsic Value, Exercised     $ 5.7 $ 1.2  
Fair Value of Shares Vested     $ 1.6 $ 0.4  
Common stock reserved for future awards or option grants   18,832,895 18,832,895   15,448,012
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value     $ 6.31 $ 2.31  
Restricted Stock Units [Member]          
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number   5,082 5,082   10,651
Equity incentive Plan 2016 and 2020 [Member]          
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]          
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized   16,018,660 16,018,660    
Equity Incentive Plan 2018 [Member]          
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]          
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized   6,634,333 6,634,333    
Common Stock [Member]          
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]          
Share purchased under employee stock purchase plan   21,899 21,899    
Equity Incentive Plans [Member]          
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Description In September 2018, ARS Pharma adopted the 2018 Equity Incentive Plan. As a result of the Merger, on November 8, 2022 ARS Pharma, as the accounting acquirer, is deemed to have assumed Silverback’s 2016 and 2020 Equity Incentive Plans, and Employee Stock Purchase Plan (“ESPP”). During the three and six months ended June 30, 2023, there were 21,899 shares of common stock purchased under the ESPP.        
Equity Incentive Plans [Member] | Equity incentive Plan 2016 and 2020 [Member]          
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number   9,753,600 9,753,600    
Common stock reserved for future awards or option grants   3,104,826 3,104,826    
Equity Incentive Plans [Member] | Equity Incentive Plan 2018 [Member]          
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number   5,634,900 5,634,900    
Common stock reserved for future awards or option grants   294,113 294,113